These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 1715593

  • 1. Role of norfluoxetine in the inhibition of desipramine metabolism and in the inhibition of serotonin uptake after fluoxetine administration to rats.
    Fuller RW, Snoddy HD.
    Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):31-40. PubMed ID: 1715593
    [Abstract] [Full Text] [Related]

  • 2. Effects of fluoxetine and norfluoxetine on 5-hydroxytryptamine metabolism in blood platelets and brain after administration to rats.
    Bourdeaux R, Desor D, Lehr PR, Younos C, Capolaghi B.
    J Pharm Pharmacol; 1998 Dec; 50(12):1387-92. PubMed ID: 10052854
    [Abstract] [Full Text] [Related]

  • 3. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo.
    Fuller RW, Snoddy HD, Krushinski JH, Robertson DW.
    Neuropharmacology; 1992 Oct; 31(10):997-1000. PubMed ID: 1279447
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of rat brain monoamine oxidase enzymes by fluoxetine and norfluoxetine.
    Holt A, Baker GB.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):17-24. PubMed ID: 8832583
    [Abstract] [Full Text] [Related]

  • 5. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms.
    Caccia S, Bizzi A, Coltro G, Fracasso C, Frittoli E, Mennini T, Garattini S.
    J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex.
    Qu Y, Aluisio L, Lord B, Boggs J, Hoey K, Mazur C, Lovenberg T.
    Pharmacol Biochem Behav; 2009 May; 92(3):469-73. PubMed ID: 19463261
    [Abstract] [Full Text] [Related]

  • 7. Drug concentrations in mouse brain at pharmacologically active doses of fluoxetine enantiomers.
    Fuller RW, Snoddy HD.
    Biochem Pharmacol; 1993 Jun 09; 45(11):2355-8. PubMed ID: 8517878
    [Abstract] [Full Text] [Related]

  • 8. Effect of fluoxetine pretreatment on plasma and tissue concentrations of desipramine in rats.
    Fuller RW, Perry KW.
    Res Commun Chem Pathol Pharmacol; 1989 Dec 09; 66(3):375-84. PubMed ID: 2609015
    [Abstract] [Full Text] [Related]

  • 9. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain.
    Wong DT, Bymaster FP, Reid LR, Mayle DA, Krushinski JH, Robertson DW.
    Neuropsychopharmacology; 1993 Jun 09; 8(4):337-44. PubMed ID: 8512621
    [Abstract] [Full Text] [Related]

  • 10. Passively administered fluoxetine reaches the juvenile brain of FSL rats and reduces antioxidant defences, without altering serotonin turnover.
    Steyn SF, Rheeders M, Viljoen FP, Brand L.
    BMC Pharmacol Toxicol; 2024 Aug 16; 25(1):51. PubMed ID: 39152503
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous quantification of fluoxetine, norfluoxetine, and desipramine using gas chromatography with nitrogen-phosphorus detection.
    Goodnough DB, Baker GB, Coutts RT.
    J Pharmacol Toxicol Methods; 1995 Nov 16; 34(3):143-7. PubMed ID: 8573764
    [Abstract] [Full Text] [Related]

  • 12. Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine.
    Baron BM, Ogden AM, Siegel BW, Stegeman J, Ursillo RC, Dudley MW.
    Eur J Pharmacol; 1988 Sep 13; 154(2):125-34. PubMed ID: 2465908
    [Abstract] [Full Text] [Related]

  • 13. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum.
    Perry KW, Fuller RW.
    Life Sci; 1992 Sep 13; 50(22):1683-90. PubMed ID: 1375306
    [Abstract] [Full Text] [Related]

  • 14. Postmortem serum and tissue redistribution of fluoxetine and norfluoxetine in dogs following oral administration of fluoxetine hydrochloride (Prozac).
    Pohland RC, Bernhard NR.
    J Forensic Sci; 1997 Sep 13; 42(5):812-6. PubMed ID: 9304827
    [Abstract] [Full Text] [Related]

  • 15. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
    Goodnough DB, Baker GB.
    J Neurochem; 1994 Jun 13; 62(6):2262-8. PubMed ID: 8189233
    [Abstract] [Full Text] [Related]

  • 16. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: relationship with brain concentrations of fluoxetine and norfluoxetine.
    Gardier AM, Lepoul E, Trouvin JH, Chanut E, Dessalles MC, Jacquot C.
    Life Sci; 1994 Jun 13; 54(4):PL51-6. PubMed ID: 8289580
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic and electrocardiographic effects of fluoxetine and its major metabolite, norfluoxetine, in anesthetized dogs.
    Steinberg MI, Smallwood JK, Holland DR, Bymaster FP, Bemis KG.
    Toxicol Appl Pharmacol; 1986 Jan 13; 82(1):70-9. PubMed ID: 3484846
    [Abstract] [Full Text] [Related]

  • 18. Brain tryptophan metabolism remained unaltered in restraint stressed rats following fluoxetine administration.
    Dawood S, Bano S.
    Pak J Pharm Sci; 2005 Jul 13; 18(3):49-54. PubMed ID: 16380345
    [Abstract] [Full Text] [Related]

  • 19. Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigs.
    Anelli M, Bizzi A, Caccia S, Codegoni AM, Fracasso C, Garattini S.
    J Pharm Pharmacol; 1992 Aug 13; 44(8):696-8. PubMed ID: 1359101
    [Abstract] [Full Text] [Related]

  • 20. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M, Afkhami-Dastjerdian S, Reader TA.
    J Psychiatry Neurosci; 1996 Mar 13; 21(2):114-22. PubMed ID: 8820177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.